Clinical Trial

Single Ascending Dose Study of ATH-097 in Healthy Participants

Name: Single Ascending Dose Study of ATH-097 in Healthy Participants — clinical trial record (NCT07640269)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a Phase I, A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ATH-097 in Healthy Participants

Trial Details

NCT Number	NCT07640269
Lead Sponsor	Atheron Therapeutics, Ltd.
Conditions	This is a Phase I Study Conducted in Healthy Volunteers
Enrollment	44 participants
Start Date	2026-07-06
Primary Completion	2026-10-20 (estimated)
Study Completion	2026-10-20 (estimated)
Updated on ClinicalTrials.gov	2026-06-10